{ C5000 CLIA analyzer }

  • Poclight CLIA POCT in Preventive and Diagnostic Health Checkups

    1.  Introduction

     

    Annual preventive screenings are more than just a routine. They help us detect subtle changes in our bodies before they become serious.

    Catching potential issues early allows us to take action sooner, manage risks effectively, and maintain our overall well-being.

    Wondering which tests are most important for a comprehensive view of your health? Today’s article may provide some guidance on essential screenings to consider during your next routine check-up.

     

    preventative care 

     

    2.  Routine Preventive Screening for General Population

     

    Preventive screening covers multiple body systems, from metabolic and cardiovascular health to thyroid function and nutritional status. Below we categorize the most relevant tests for general adults, explaining their purpose, recommended population, and associated health risks.

     

    Category

    Markers

    Purpose

    Recommended Population

    Related Conditions / Risks

    Allergy / Immune Sensitivity

    Immunoglobulin E (IgE) Test Kit

    Detects allergic sensitization

    Allergy-prone individuals

    Family history of allergy

    Allergic rhinitis

    Asthma

    Other allergic conditions

    Cardiovascular

    BNP

    NT-proBNP

    hs-cTnT

    Evaluates cardiac stress and early myocardial risk

    Adults over 40,

    adults with family history of heart disease

    Early heart strain, myocardial injury

    Thyroid Function

    TSH

    FT3

    FT4

    Evaluates thyroid hormone balance

    Individuals with fatigue, weight changes, or metabolic concerns

    Hypothyroidism

    Hyperthyroidism

    Glucose

    HbA1c

    Insulin

    Monitors long-term glucose control

    Adults at risk for metabolic disorders, overweight, or with lifestyle-related risk factors

    Diabetes, Prediabetes

    Nutritional Status

    Ferritin

    25-OH VD

    Active B12

    Assesses iron and vitamin status to detect deficiencies

    General adult population, elderly, individuals with restrictive diet

    Anemia, vitamin D deficiency, vitamin B12 deficiency

     

    Risk-Based Tumor Marker Testing

     

    Cancer screening using specific biomarkers is not part of routine check-ups for the general population. Instead, these tests are recommended for individuals at higher risk or under physician guidance to support early detection and targeted health monitoring.

    Category

    Markers

    Purpose

    Recommended Population

    Related Conditions / Risks

    Cancer Screening

    tPSA

    fPSA

    CEA

    AFP

    CYFRA21-1

    CA19-9

    CA125

    Supports risk awareness and baseline health monitoring

    Individuals with relevant family histories or personal cancer histories

    Prostate cancer, liver cancer, lung & digestive system cancers, ovarian cancer

     

    3.  How Poclight CLIA POCT Supports Preventive Screening Programs

     

    With the advancement of CLIA Point-of-Care Testing, high-quality laboratory diagnostics can now be delivered rapidly at the point of care, making multi-parameter screening feasible in routine health examinations.

     

    C5000

     

    Poclight C5000 micro CLIA analyzer helps laboratories and clinics deliver laboratory-grade results with point-of-care efficiency, offering:

     

    ● Rapid results: delivers accurate results in 3-15 minutes across 40+ tests

    ● Stable reagents: freeze-dried reagents storable at 2-30°C for up to 18 months

    ● User-friendly operation: simple 3-step workflow within a compact 8.5 kg analyzer

    key features

     

    For partnership and distribution inquiries, please contact us.

  • Poclight IgE Assay Accurate Insights into Allergic Diseases

     

    1.  What is IgE?

     

    In our blood, there exists a special class of protein known as immunoglobulin, which is an important component of the immune system. Among them, IgE (immunoglobulin E), despite its extremely low concentration, accounting for only 0.002% of the total immunoglobulin, it acts as a key "messenger" in triggering allergic reactions. This antibody produced by B lymphocytes primarily protects the human body in two ways: one is to resist parasitic infections, and the other is to trigger an immune response when encountering allergens.

     

    When allergens (such as pollen, dust mites or certain foods) enter the human body, the immune system recognizes them as "foreign invaders" and prompts B cells to produce IgE antibodies against the allergen. These IgE will specifically bind to the surface of mast cells and basophils, causing the body to enter a "sensitized state". When exposed to the same allergen again, IgE immediately activates the "alarm system", prompting cells to release inflammatory mediators such as histamine, triggering allergic symptoms like sneezing, itchy skin, and breathing difficulties - this is the fundamental principle of what we commonly refer to as an allergic reaction.

     

    2.  IgE Testing: Purpose and Applications

     

    IgE detection has become a critical tool in the diagnosis of allergic diseases.

     

    IgE Assay Application

     

    Clinical significance: Studies show that approximately 30% of patients with allergic diseases exhibit significantly elevated levels of total serum IgE. Moreover, specific IgE testing demonstrates over 85% accuracy in identifying the types of allergens involved. This test is mainly applicable to three types of people:

    ✓ Patients with recurrent skin itching, urticaria, allergic rhinitis and other symptoms.

    ✓ Individuals with a history of asthma and unknown cause.

    ✓ High-risk groups with a family history of allergic diseases.

     

    Note: IgE test results must be interpreted in conjunction with clinical symptoms. For instance, in patients with hay fever, allergen-specific IgE levels may rise 2-4 weeks before the pollen season begins. In cases of food allergy, relevant IgE antibodies can trigger an immune response within 1-2 hours after ingestion of the allergenic food. Through dynamic monitoring of IgE levels, physicians can not only confirm a diagnosis but also develop personalized desensitization treatment plans, which have been shown to reduce the risk of acute asthma attacks by 40%-60%.

     

    3.  From Testing to Management: Comprehensive Prevention and Control of Allergic Diseases

     

    IgE testing is only the first step in the management of allergic diseases. Clinical practice has shown that personalized prevention and control plans, developed based on test results, can improve patients' quality of life scores by 35%~50%. For patients allergic to dust mites, in addition to the use of antihistamines, regular environmental control measures, such as using mite-proof bedding and air purifiers, can reduce the frequency of symptom episodes by 40%. Patients with food allergies, on the other hand, need to strictly avoid allergenic foods and carry an epinephrine auto-injector at all times in case of accidental exposure.

     

    IgE Test Kit

     

    With advances in precision medicine, IgE testing technology is also continuously evolving. The new generation of testing methods can not only quantitatively analyze antibody levels but also predict the severity of allergic reactions by detecting IgE subtypes.

     

    In an era of ongoing iteration in in vitro diagnostic technologies, Poclight IgE test kit, with its innovative technology, exceptional performance, user-friendly operation, and reliable quality, offers a new option for the precise diagnosis of allergic diseases. In the future, by integrating genetic testing and artificial intelligence algorithms, we hope to achieve early warning and precise intervention for allergic diseases, helping more people break free from the burden of allergies.

     

    Advantages of Poclight IgE Test Kit: Innovative CRET Technology Enables Precision "Signal-Switch" Detection

     

    C5000 POCT Analyzer

     

    Technology Principle:

    ✓ Utilizes a homogeneous chemiluminescence approach.

    ✓ Integrates antigen-antibody reactions with chemiluminescent signals.

     

    Workflow:

    ● The target substance binds with an acridinium ester-labeled DNA antibody to form an immunocomplex.

    ● Graphene oxide quenches the remaining unbound acridinium ester-labeled DNA fragments.

    ● This homogeneous process eliminates the need for separation and washing steps.

    ● A chemiluminescent reaction is initiated by adding an excitation solution.

     

    Performance Specifications:

    ✓ High Sensitivity: Detection sensitivity of 0.1 IU/mL.

    ✓ Wide Linear Range: 0.1–2500 IU/mL, fully meeting clinical testing requirements.

    ✓ Excellent Precision: Intra-assay CV ≤10% and inter-assay CV ≤15%, ensuring stable and reliable results.

    ✓ Rapid detection: in just 5 minutes, minimal sample volume of 50 µL, simple operation, low cost, high-quality CLIA methodology, innovative CRET patented technology, precise results, and a wide linear detection range.

    ✓ Ease of Use: Minimal training required

     

    Key Advantage (vs. Traditional ELISA):

     

    ●  Exceptional Speed: Reduces the detection time from 3 hours to just 5 minutes.

    ●  Operational Simplicity: The homogeneous assay format removes the need for cumbersome washing and separation steps.

    Compatible with Poclight C5000 POC CLIA Analyzer

     

     

    Operation

     

    To learn more about cooperation regarding Poclight's 5-generation CLIA solutions, please contact us.

     

  • World Stroke Day Poclight CRET for Hidden Stroke Detection

     
    1.  The Invisible Warning: Activated Platelets

     

    October 29 marks World Stroke Day, a reminder to pay attention to brain health and take action to prevent strokes, one of the leading causes of death and disability worldwide.

    Strokes can occur suddenly, and certain physiological changes may precede clinical symptoms. Early detection is therefore essential for timely risk assessment and intervention.

     

    Many people associate stroke with high blood pressure, high cholesterol, and atherosclerosis. While these are important risk factors, there’s a crucial, often overlooked element — abnormal platelet activation.

    Normal platelets help stop bleeding, but when excessively activated, they become overly sticky and prone to clumping. Like tiny “time bombs,” they can form blood clots that block cerebral blood vessels, leading to ischemic stroke.

    Traditional blood tests may not fully reflect platelet activation; direct monitoring of platelet functional state provides more comprehensive information.

     

    2.  The Gold Standard: Platelet Activation Markers

     

    Early detection of platelet activation is key to predicting thrombotic events. Important markers include:

     

    Platelet Activation Markers

     

    ● CD62P (P-Selectin): Recognized as the gold standard for platelet activation. Its surface expression signals the initiation of clot formation.

    ● PAC-1: A widely accepted marker for early platelet activation.

    ● CD42a, CD42b, CD41, CD61: Maintain platelet structure and function, mediating aggregation, adhesion, and secretion.

    These markers allow clinicians to precisely assess platelet activation and intervene before stroke occurs.

     

    Testing Significance

     

    1)  Personalized Antiplatelet Therapy

    Provides precise guidance for the use of antiplatelet drugs such as aspirin and clopidogrel, enabling individualized treatment.

    2)  Stroke Risk Assessment

    Detects hidden hypercoagulable states in time, offering early warning for cardiovascular and cerebrovascular events.

    3)  Medication Guidance & Efficacy Monitoring

    Evaluates whether antiplatelet therapy is effective and identifies potential “drug resistance,” allowing timely adjustment of treatment plans.

     

    3.  CRET Platelet Activation Measurement

     

    Poclight Platelet Activation Function Analyzer: Real-Time, Dynamic, and Precise

    Poclight CRET Analyzer and reagents offers a powerful tool for platelet monitoring, helping clinicians make informed decisions regarding transfusion strategies, bleeding/thrombosis risk prediction, and treatment optimization.

     

    Poclight Platelet Activation Features

     

    With CRET Measurement, clinicians can detect the “invisible” culprits of stroke early, enabling timely intervention and improved patient outcomes.

     

    For detailed information and partnership options, please contact us.